{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,6,6]],"date-time":"2025-06-06T07:07:50Z","timestamp":1749193670879},"reference-count":36,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2013,4,10]],"date-time":"2013-04-10T00:00:00Z","timestamp":1365552000000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocrine"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1007\/s12020-013-9951-9","type":"journal-article","created":{"date-parts":[[2013,4,9]],"date-time":"2013-04-09T15:48:38Z","timestamp":1365522518000},"page":"106-113","source":"Crossref","is-referenced-by-count":14,"title":["Circulating glucagon to ghrelin ratio as a determinant of insulin resistance in hyperthyroidism"],"prefix":"10.1007","volume":"45","author":[{"given":"Kemal","family":"A\u011fbaht","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Murat Faik","family":"Erdogan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rifat","family":"Emral","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nilgun","family":"Baskal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sevim","family":"G\u00fcll\u00fc","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,4,10]]},"reference":[{"key":"9951_CR1","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1089\/10507250252949405","volume":"12","author":"LH Duntas","year":"2002","unstructured":"L.H. Duntas, Thyroid disease and lipids. Thyroid 12, 287\u2013293 (2002)","journal-title":"Thyroid"},{"key":"9951_CR2","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/35007534","volume":"404","author":"MW Schwartz","year":"2000","unstructured":"M.W. Schwartz, S.C. Woods, D. Porte Jr, R.J. Seeley, D.G. Baskin, Central nervous system control of food intake. Nature 404, 661\u2013671 (2000)","journal-title":"Nature"},{"key":"9951_CR3","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1053\/beem.2002.0230","volume":"16","author":"A Sainsbury","year":"2002","unstructured":"A. Sainsbury, G.J. Cooney, H. Herzog, Hypothalamic regulation of energy homeostasis. Best Pract. Res. Clin. Endocrinol. Metab. 16, 623\u2013637 (2002)","journal-title":"Best Pract. Res. Clin. Endocrinol. Metab."},{"key":"9951_CR4","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.2337\/diabetes.52.10.2546","volume":"52","author":"SM Poykko","year":"2003","unstructured":"S.M. Poykko, E. Kellokoski, S. Horkko, H. Kauma, Y.A. Kesaniemi, O. Ukkola, Low plasma ghrelin is associated with insulin resistance, hypertension, and the prevalence of type 2 diabetes. Diabetes 52, 2546\u20132553 (2003)","journal-title":"Diabetes"},{"key":"9951_CR5","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.2337\/diabetes.51.12.3408","volume":"51","author":"A Ikezaki","year":"2002","unstructured":"A. Ikezaki, H. Hosoda, K. Ito, S. Iwama, N. Miura, H. Matsuoka, C. Kondo, M. Kojima, K. Kangawa, S. Sugihara, Fasting plasma ghrelin levels are negatively correlated with insulin resistance and PAI-1, but not with leptin, in obese children and adolescents. Diabetes 51, 3408\u20133411 (2002)","journal-title":"Diabetes"},{"issue":"2","key":"9951_CR6","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1007\/s12020-012-9761-5","volume":"43","author":"Y Li","year":"2012","unstructured":"Y. Li, J. Hai, L. Li, X. Chen, H. Peng, M. Cao, Q. Zhang, Administration of ghrelin improves inflammation, oxidative stress, and apoptosis during and after non-alcoholic fatty liver disease development. Endocrine 43(2), 376\u2013386 (2012)","journal-title":"Endocrine"},{"key":"9951_CR7","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s12020-012-9680-5","volume":"42","author":"BW Liu","year":"2012","unstructured":"B.W. Liu, Q. Lu, C.M. Ma, J.R. Liu, D.H. Lou, X.L. Liu, F.Z. Yin, The study of soluble intercellular adhesion molecule-1 and ghrelin in adolescents with family history of type 2 diabetes. Endocrine 42, 599\u2013605 (2012)","journal-title":"Endocrine"},{"issue":"2","key":"9951_CR8","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s12020-012-9800-2","volume":"43","author":"PJ Delhanty","year":"2012","unstructured":"P.J. Delhanty, A.J. van der Lely, Ghrelin: a new treatment for non-alcoholic fatty liver disease? Endocrine 43(2), 247\u2013248 (2012)","journal-title":"Endocrine"},{"key":"9951_CR9","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1210\/me.2011-1001","volume":"25","author":"JC Chuang","year":"2011","unstructured":"J.C. Chuang, I. Sakata, D. Kohno, M. Perello, S. Osborne-Lawrence, J.J. Repa, J.M. Zigman, Ghrelin directly stimulates glucagon secretion from pancreatic alpha-cells. Mol. Endocrinol. 25, 1600\u20131611 (2011)","journal-title":"Mol. Endocrinol."},{"key":"9951_CR10","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1530\/eje.1.01981","volume":"153","author":"MA Arafat","year":"2005","unstructured":"M.A. Arafat, B. Otto, H. Rochlitz, M. Tschop, V. Bahr, M. Mohlig, S. Diederich, J. Spranger, A.F. Pfeiffer, Glucagon inhibits ghrelin secretion in humans. Eur. J. Endocrinol. 153, 397\u2013402 (2005)","journal-title":"Eur. J. Endocrinol."},{"key":"9951_CR11","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1159\/000092603","volume":"65","author":"AE Altinova","year":"2006","unstructured":"A.E. Altinova, F.B. Toruner, M. Akturk, S. Elbeg, I. Yetkin, N. Cakir, M. Arslan, Reduced serum acylated ghrelin levels in patients with hyperthyroidism. Horm. Res. 65, 295\u2013299 (2006)","journal-title":"Horm. Res."},{"key":"9951_CR12","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1530\/eje.1.01934","volume":"153","author":"O Gimenez-Palop","year":"2005","unstructured":"O. Gimenez-Palop, G. Gimenez-Perez, D. Mauricio, E. Berlanga, N. Potau, C. Vilardell, J. Arroyo, J.M. Gonzalez-Clemente, A. Caixas, Circulating ghrelin in thyroid dysfunction is related to insulin resistance and not to hunger, food intake or anthropometric changes. Eur. J. Endocrinol. 153, 73\u201379 (2005)","journal-title":"Eur. J. Endocrinol."},{"key":"9951_CR13","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1210\/jc.2002-021302","volume":"88","author":"AL Riis","year":"2003","unstructured":"A.L. Riis, T.K. Hansen, N. Moller, J. Weeke, J.O. Jorgensen, Hyperthyroidism is associated with suppressed circulating ghrelin levels. J. Clin. Endocrinol. Metab. 88, 853\u2013857 (2003)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9951_CR14","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1055\/s-0030-1269880","volume":"119","author":"G Dimitriadis","year":"2011","unstructured":"G. Dimitriadis, E. Hatziagelaki, P. Mitrou, V. Lambadiari, E. Maratou, A.E. Raptis, J.E. Gerich, S.A. Raptis, Effect of hyperthyroidism on clearance and secretion of glucagon in man. Exp. Clin. Endocrinol. Diabetes 119, 214\u2013217 (2011)","journal-title":"Exp. Clin. Endocrinol. Diabetes"},{"key":"9951_CR15","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1089\/thy.2007.0016","volume":"17","author":"N Pontikides","year":"2007","unstructured":"N. Pontikides, G.E. Krassas, Basic endocrine products of adipose tissue in states of thyroid dysfunction. Thyroid 17, 421\u2013431 (2007)","journal-title":"Thyroid"},{"key":"9951_CR16","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","volume":"28","author":"DR Matthews","year":"1985","unstructured":"D.R. Matthews, J.P. Hosker, A.S. Rudenski, B.A. Naylor, D.F. Treacher, R.C. Turner, Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28, 412\u2013419 (1985)","journal-title":"Diabetologia"},{"key":"9951_CR17","doi-asserted-by":"crossref","first-page":"707","DOI":"10.2337\/diabetes.50.4.707","volume":"50","author":"M Tschop","year":"2001","unstructured":"M. Tschop, C. Weyer, P.A. Tataranni, V. Devanarayan, E. Ravussin, M.L. Heiman, Circulating ghrelin levels are decreased in human obesity. Diabetes 50, 707\u2013709 (2001)","journal-title":"Diabetes"},{"key":"9951_CR18","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.1210\/jc.2002-021669","volume":"88","author":"J Nedvidkova","year":"2003","unstructured":"J. Nedvidkova, I. Krykorkova, V. Bartak, H. Papezova, P.W. Gold, S. Alesci, K. Pacak, Loss of meal-induced decrease in plasma ghrelin levels in patients with anorexia nervosa. J. Clin. Endocrinol. Metab. 88, 1678\u20131682 (2003)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9951_CR19","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1385\/ENDO:27:1:055","volume":"27","author":"S Rojdmark","year":"2005","unstructured":"S. Rojdmark, J. Calissendorff, O. Danielsson, K. Brismar, Hunger-satiety signals in patients with Graves\u2019 thyrotoxicosis before, during, and after long-term pharmacological treatment. Endocrine 27, 55\u201361 (2005)","journal-title":"Endocrine"},{"key":"9951_CR20","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1055\/s-0030-1269853","volume":"43","author":"J Kosowicz","year":"2011","unstructured":"J. Kosowicz, A. Baumann-Antczak, M. Ruchala, M. Gryczynska, E. Gurgul, J. Sowinski, Thyroid hormones affect plasma ghrelin and obestatin levels. Horm. Metab. Res. 43, 121\u2013125 (2011)","journal-title":"Horm. Metab. Res."},{"key":"9951_CR21","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.pharmthera.2008.02.008","volume":"118","author":"K Dezaki","year":"2008","unstructured":"K. Dezaki, H. Sone, T. Yada, Ghrelin is a physiological regulator of insulin release in pancreatic islets and glucose homeostasis. Pharmacol. Ther. 118, 239\u2013249 (2008)","journal-title":"Pharmacol. Ther."},{"key":"9951_CR22","first-page":"E593","volume":"248","author":"G Dimitriadis","year":"1985","unstructured":"G. Dimitriadis, B. Baker, H. Marsh, L. Mandarino, R. Rizza, R. Bergman, M. Haymond, J. Gerich, Effect of thyroid hormone excess on action, secretion, and metabolism of insulin in humans. Am. J. Physiol. 248, E593\u2013E601 (1985)","journal-title":"Am. J. Physiol."},{"key":"9951_CR23","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1210\/er.2009-0046","volume":"31","author":"P Mitrou","year":"2010","unstructured":"P. Mitrou, S.A. Raptis, G. Dimitriadis, Insulin action in hyperthyroidism: a focus on muscle and adipose tissue. Endocr. Rev. 31, 663\u2013679 (2010)","journal-title":"Endocr. Rev."},{"key":"9951_CR24","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1210\/jc.2005-0960","volume":"91","author":"G Dimitriadis","year":"2006","unstructured":"G. Dimitriadis, P. Mitrou, V. Lambadiari, E. Boutati, E. Maratou, E. Koukkou, M. Tzanela, N. Thalassinos, S.A. Raptis, Glucose and lipid fluxes in the adipose tissue after meal ingestion in hyperthyroidism. J. Clin. Endocrinol. Metab. 91, 1112\u20131118 (2006)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9951_CR25","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1210\/jcem-50-2-392","volume":"50","author":"UM Kabadi","year":"1980","unstructured":"U.M. Kabadi, A.B. Eisenstein, Glucose intolerance in hyperthyroidism: role of glucagon. J. Clin. Endocrinol. Metab. 50, 392\u2013396 (1980)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9951_CR26","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1210\/jcem-51-3-478","volume":"51","author":"UM Kabadi","year":"1980","unstructured":"U.M. Kabadi, A.B. Eisenstein, Impaired pancreatic alpha-cell response in hyperthyroidism. J. Clin. Endocrinol. Metab. 51, 478\u2013482 (1980)","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"9951_CR27","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1172\/JCI107692","volume":"53","author":"JE Gerich","year":"1974","unstructured":"J.E. Gerich, M. Langlois, C. Noacco, V. Schneider, P.H. Forsham, Adrenergic modulation of pancreatic glucagon secretion in man. J. Clin. Invest. 53, 1441\u20131446 (1974)","journal-title":"J. Clin. Invest."},{"key":"9951_CR28","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cyto.2007.10.001","volume":"40","author":"P Iglesias","year":"2007","unstructured":"P. Iglesias, J.J. Diez, Influence of thyroid dysfunction on serum concentrations of adipocytokines. Cytokine 40, 61\u201370 (2007)","journal-title":"Cytokine"},{"key":"9951_CR29","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1530\/eje.0.1460607","volume":"146","author":"H Wahrenberg","year":"2002","unstructured":"H. Wahrenberg, A. Wennlund, J. Hoffstedt, Increased adipose tissue secretion of interleukin-6, but not of leptin, plasminogen activator inhibitor-1 or tumour necrosis factor alpha, in Graves\u2019 hyperthyroidism. Eur. J. Endocrinol. 146, 607\u2013611 (2002)","journal-title":"Eur. J. Endocrinol."},{"key":"9951_CR30","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1080\/152873901316857752","volume":"63","author":"R Seven","year":"2001","unstructured":"R. Seven, Thyroid status and leptin in Basedow-Graves and multinodular goiter patients. J. Toxicol. Environ. Health A. 63, 575\u2013581 (2001)","journal-title":"J. Toxicol. Environ. Health A."},{"key":"9951_CR31","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1530\/eje.0.1370659","volume":"137","author":"S Corbetta","year":"1997","unstructured":"S. Corbetta, P. Englaro, S. Giambona, L. Persani, W.F. Blum, P. Beck-Peccoz, Lack of effects of circulating thyroid hormone levels on serum leptin concentrations. Eur. J. Endocrinol. 137, 659\u2013663 (1997)","journal-title":"Eur. J. Endocrinol."},{"key":"9951_CR32","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1002\/jcb.20188","volume":"93","author":"S Yaturu","year":"2004","unstructured":"S. Yaturu, S. Prado, S.R. Grimes, Changes in adipocyte hormones leptin, resistin, and adiponectin in thyroid dysfunction. J. Cell. Biochem. 93, 491\u2013496 (2004)","journal-title":"J. Cell. Biochem."},{"key":"9951_CR33","doi-asserted-by":"crossref","first-page":"741","DOI":"10.2119\/2008-00058.Rabe","volume":"14","author":"K Rabe","year":"2008","unstructured":"K. Rabe, M. Lehrke, K.G. Parhofer, U.C. Broedl, Adipokines and insulin resistance. Mol. Med. 14, 741\u2013751 (2008)","journal-title":"Mol. Med."},{"key":"9951_CR34","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.cmet.2004.12.004","volume":"1","author":"R Coppari","year":"2005","unstructured":"R. Coppari, M. Ichinose, C.E. Lee, A.E. Pullen, C.D. Kenny, R.A. McGovern, V. Tang, S.M. Liu, T. Ludwig, S.C. Chua Jr, B.B. Lowell, J.K. Elmquist, The hypothalamic arcuate nucleus: a key site for mediating leptin\u2019s effects on glucose homeostasis and locomotor activity. Cell Metab. 1, 63\u201372 (2005)","journal-title":"Cell Metab."},{"key":"9951_CR35","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.cmet.2007.06.003","volume":"6","author":"N Kubota","year":"2007","unstructured":"N. Kubota, W. Yano, T. Kubota, T. Yamauchi, S. Itoh, H. Kumagai, H. Kozono, I. Takamoto, S. Okamoto, T. Shiuchi, R. Suzuki, H. Satoh, A. Tsuchida, M. Moroi, K. Sugi, T. Noda, H. Ebinuma, Y. Ueta, T. Kondo, E. Araki, O. Ezaki, R. Nagai, K. Tobe, Y. Terauchi, K. Ueki, Y. Minokoshi, T. Kadowaki, Adiponectin stimulates AMP-activated protein kinase in the hypothalamus and increases food intake. Cell Metab. 6, 55\u201368 (2007)","journal-title":"Cell Metab."},{"key":"9951_CR36","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1016\/j.metabol.2005.05.011","volume":"54","author":"T Saito","year":"2005","unstructured":"T. Saito, T. Kawano, A. Ikoma, K. Namai, H. Tamemoto, M. Kawakami, S.E. Ishikawa, Elevation of serum adiponectin levels in Basedow disease. Metabolism 54, 1461\u20131466 (2005)","journal-title":"Metabolism"}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-013-9951-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12020-013-9951-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-013-9951-9","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,12]],"date-time":"2019-07-12T06:29:20Z","timestamp":1562912960000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12020-013-9951-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,4,10]]},"references-count":36,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["9951"],"URL":"https:\/\/doi.org\/10.1007\/s12020-013-9951-9","relation":{},"ISSN":["1355-008X","1559-0100"],"issn-type":[{"value":"1355-008X","type":"print"},{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,4,10]]}}}